October 1, 2020

The Niche

Knoepfler lab stem cell blog

Federal of State Medical Boards stem cells

4 min read

We have a big problem with clinics in the U.S. selling unproven and non-FDA approved stem cell “treatments” to patients and part of the reason in my view why we have this mess today with upwards of 700 such businesses from coast to coast is that regulators including both the FDA and state medical boards haven’t realized the scope of the clinic industry and/or taken proportionate action accordingly. There are signs that this lack of the needed scope of regulatory oversight may be changing …Read More